Loading compound...
Small molecule cancer research compound
Dolastatin-10 is a small molecule currently being studied in clinical trials (Phase 2) for various types of cancer, including leukemia, lymphoma, and several solid tumors like pancreatic and kidney cancer.
How it worksDolastatin-10 is a small molecule compound being investigated for its ability to treat several types of cancer cells.
Used for
LeukemiaLymphomaSarcomaPancreatic cancerKidney cancerGallbladder cancerOvarian cancerProstate cancer
Conditions
LeukemiaLymphomaSarcomaPancreatic carcinomaKidney cancerGallbladder cancerOvarian cancerProstate cancer
Class
Small moleculeSmall molecule cancer research compound
How to take
Dolastatin-10 is currently in Phase 2 clinical trials and is not yet an FDA-approved medication for general use.
Talk to your doctor
Questions to ask
- ·Is Dolastatin-10 part of any clinical trials I can join?
- ·How does Dolastatin-10 differ from my current cancer treatment?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
